Hirohito Yamazaki

11PUBLICATIONS
48CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyCauses and prevention of crimeInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 29, 2026
Long-term efficacy and safety of romiplostim plus immunosuppressive therapy as first-line treatment in patients with aplastic anaemia: 2-year interim analysis of observational study of two clinical trials.

|Aug 04, 2025
Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Jong Wook Lee, Jun Ho Jang, Hirohito Yamazaki

|Feb 10, 2024
Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Ryusuke Yamamoto, Nobuhiro Hiramoto, Ayumi Fujimoto

|Aug 25, 2023
Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.

Noriaki Tsuji, Kohei Hosokawa, Ryota Urushihara

|Aug 21, 2023
Familial immune-mediated aplastic anaemia in six different families.

Tatsuya Imi, Hiroki Mizumaki, Kazuyoshi Hosomichi

|Apr 27, 2022
Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.

Noriaki Tsuji, Kohei Hosokawa, Ryota Urushihara

Pageof 2

Frequent Collaborators

7 joint publications

Shinji Nakao

6 joint publications

Kohei Hosokawa

4 joint publications

Ken Ishiyama

3 joint publications

Seishi Ogawa